📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $210.12666
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. Analysts project a 1.5% potential upside. Currently trading at a Forward P/E of 17.95168.